| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0029 | 1 |